Selection from HEOR Bibliography
| Search criteria | ||||
| Netherlands |
||||
| Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 | ||||
| Janet Sultana 1 2, Salvatore Crisafulli 3, Mariana Almas 4, Ippazio Cosimo Antonazzo 5 6, Esme Baan 7, Claudia Bartolini 6, Maria Paola Bertuccio 3, Fedele Bonifazi 8 9, Annalisa Capuano 10 11, Antonella Didio 8 9, Vera Ehrenstein 12, Mariagrazia Felisi 8 13, Carmen Ferrajolo 10 11, Andrea Fontana 14, Remy Francisca 7, Annie Fourrier-Reglat 15, Joan Fortuny 16, Rosa Gini 6, Giulia Hyeraci 6, Christel Hoeve 7, Christos Kontogiorgis 17, Valentina Isgrò 18, Panagiotis-Nikolaos Lalagkas 17, Luca L'Abbate 18, Deborah Layton 19, Annalisa Landi 8 9, Silvia Narduzzi 19, Leonardo Roque Pereira 20, Georgios Poulentzas 17, Concetta Rafaniello 10 11, Giuseppe Roberto 6, Giulia Scondotto 3, Liberata Sportiello 10 11, Maddalena Toma 8 9, Massoud Toussi 19, Katia Verhamme 7, Elisabetta Volpe 8 9, Gianluca Trifirò 18, | ||||
| Pharmacy Department, Mater Dei Hospital, Msida, Malta. 2Exeter College of Medicine and Health, Exeter, UK. 3Department of Medicine, University of Verona, Verona, Italy. 4Real World Solutions Department, IQVIA, Lisbon, Portugal. 5Research Centre on Public Health (CESP), University of Milan-Bicocca, Milan, Italy. 6Agenzia Regionale di Sanità della Toscana, Florence, Italy. 7Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, The Netherlands. 8TEDDY European Network of Excellence for Paediatric Clinical Research, Pavia, Italy. 9Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Bari, Italy. 10Department of Experimental Medicine, University of Campania "Vanvitelli", Naples, Italy. 11Campania Regional Center of Pharmacovigilance and Pharmacoepidemiology, Naples, Italy. 12Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark. 13CVBF Consorzio per Valutazioni Biologiche e Farmacologiche, Pavia, Italy. 14Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. 15Univ. Bordeaux, INSERM, Bordeaux Population Health Research Center, Team of Pharmacoepidemiology, UMR 1219, Bordeaux, France. 16RTI Health Solutions, Barcelona, Spain. 17Democritus University of Thrace, Alexandroupolis, Greece. 18Department of Diagnostics and Public Health, University of Verona, Verona, Italy. 19Data Science Hub, Real World Solutions, IQVIA, London, UK. 20Department of Datascience & Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands. | ||||
| Pharmacoepidemiol Drug Saf . 2022 Jun;31(6):689-705. doi: 10.1002/pds.5413. Epub 2022 Feb 11. |
||||
| , Article | ||||
| , Denmark, France, Italy, Netherlands, Portugal, Spain, UK | ||||
| Abstract: https://pubmed.ncbi.nlm.nih.gov/35092329/ | ||||
| Condition | Year | Language | Analysis type | |
| , Drug safety, Drug Utlization Study | 2022 | English | , Database Study, Review | |
| The Certainty Framework for Assessing Real‐World Data in Studies of Medical Product Safety and Effectiveness | ||||
| Noelle M. Cocoros Peter Arlett Nancy A. Dreyer Chieko Ishiguro Solomon Iyasu Miriam Sturkenboom Wei Zhou Sengwee Toh | ||||
| 1Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA. 2Data Analytics and Methods Task Force, European Medicines Agency, Amsterdam, The Netherlands. 3London School of Hygiene and Tropic Medicine, London, UK. 4Center for Advanced Evidence Generation, IQVIA Real World Solutions, Cambridge, Massachusetts, USA. 5Division of Epidemiology, Office of Medical Informatics and Epidemiology, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan. 6Center for Observational and Real-world Evidence, Merck & Co., Inc., Kenilworth, New Jersey, USA. 7Julius Center, Global Health, University Medical Center Utrecht, Utrecht, The Netherlands. | ||||
| https://doi.org/10.1002/cpt.2045 |
||||
| , Article | ||||
| , Japan, Netherlands, USA | ||||
| Abstract: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2045 | ||||
| Condition | Year | Language | Analysis type | |
| , Health status & patient reported outcomes | 2020 | English | , direct to patient research, Real World Data, Real World Evidence | |
| Cost effectiveness of cladribine tablets for treatment of RRMS in the Netherlands | ||||
| de Francesco M1, Mahajan K2, Michels RE3, Schiffers K4, Budhia S5, Harty G6, Krol M3 | ||||
| 1IQVIA, Zaventem, Belgium, 2IQVIA, Gurgaon, India, 3IQVIA, Amsterdam, The Netherlands, 4Merck B.V., an affiliate of Merck KGaA, Schiphol-Rijk, The Netherlands, 5PAREXEL International, Waltham, MA, USA, 6EMD Serono, Billerica, MA, USA | ||||
| 2018-11, ISPOR Europe 2018, Barcelona, Spain |
||||
| , Article | ||||
| , Netherlands | ||||
| Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/ispor-europe-2018/cost-effectiveness-of-cladribine-tablets-for-treatment-of-rrms-in-the-netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Neurological disorders | 2019 | English | , Cost effectiveness, Predictive analytics | |
| Dutch health state utilities for infertility and subfertility. | ||||
| Krol M, Nap A, Michels RM, Veraart CPWM, Goossens LMA | ||||
| IQVIA, Netherlands | ||||
| ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain |
||||
| , Abstract | ||||
| , Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Health economics, Health status & patient reported outcomes | 2018 | English | , Quality of life, Utility analysis | |
| Cost effectiveness of cladribine tablets for treatmetn of RMS in The Netherlands. | ||||
| De Francesco M1, Mahajan K2, Michels R3, Schiffers K4, Budhia S5, Harty G5, Krol M3 | ||||
| 1 IQVIA, Zaventem, Belgium 2 IQVIA, India Michels 3 IQVIA, Netherlands 4 Merck, Netherlands 5 Merck, UK | ||||
| ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain |
||||
| , Abstract | ||||
| , Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Neurological disorders | 2018 | English | , Cost effectiveness, Cost utility | |
| Healthcare utilization and costs of multiple sclerosis patients in the Netherlands: a healthcare claims database study. | ||||
| Buijs S1, Krol M2, de Voer G3 | ||||
| 1 Healthcare Insights, Netherlands 2 IQVIA, Netherlands 3 Merck, Netherlands | ||||
| Journal of Comparative Effectiveness Research, 2018, Vol. 7, No. 5 |
||||
| , Article | ||||
| , Netherlands | ||||
| Abstract: https://www.futuremedicine.com/doi/10.2217/cer-2017-0077 | ||||
| Condition | Year | Language | Analysis type | |
| , Neurological disorders | 2018 | English | , Cost of illness | |
| TREATMENT AND DOSING PATTERNS AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) INITIATING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) IN SEVERAL COUNTRIES | ||||
| Norrbacka K, Divino V, Boye K, Lebrec J, Dekoven M | ||||
| Eli Lilly, IQVIA | ||||
| ISPOR Europe 2018 |
||||
| , Poster | ||||
| , Belgium, Canada, France, Germany, Italy, Netherlands | ||||
| Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84796?pdfid=57383 | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2018 | English | , Retrospective database analysis | |
| Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis | ||||
| Marieke Krol1, Gert de Voer2, Ulrike Osowski3 | ||||
| 1QuintilesIMS, Capelle aan den Ijssel, the Netherlands; 2Merck B.V., Schiphol-Rijk, the Netherlands; 3Merck KGaA, Darmstadt, Germany | ||||
| Patient Preference and Adherence 2017:11 1189–1196 |
||||
| , Article | ||||
| , Germany, Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Gastrointestinal disorders | 2017 | English | , Retrospective cohort analysis, Retrospective database analysis | |
| Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model | ||||
| Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7 | ||||
| 1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany | ||||
| JHEOR 2017;5(1):89-108 |
||||
| , Article | ||||
| , Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Immunology and Vaccination, Infectious disease, Respiratory disease | 2017 | English | , Epidemiological study, Public Health | |
| Patient adherence to subcutaneous IFN beta-1a injections using the Rebismart® injection device:a retrospective real-world among Dutch and German patients with multiple sclerosis. | ||||
| Krol M1, deVoer G2, Osowski U3 | ||||
| 1 QuintilesIMS, The Netherlands 2 Merck B.V., Schiphol-Rijk, the Netherlands 3 Merck KGaA, Darmstadt, Germany | ||||
| , Article | ||||
| , Germany, Netherlands | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513881/ | ||||
| Condition | Year | Language | Analysis type | |
| , Neurological disorders | 2017 | English | , clinical setting: Secondary care, Compliance, Retrospective database analysis | |
| Evaluation of the effectiveness of risk minimisation measures: a survey among health care professionals to assess their knowledge and attitudes on prescribing conditions of Instanyl® in France and the Netherlands. | ||||
| Toussi M1, Garofano A1, Jouaville L1, Bardoulat I1, Mitrofan L1 | ||||
| 1 QuintilesIMS, La Défense, France | ||||
| 33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2017, August 26-30, Montreal, Canada |
||||
| , Poster | ||||
| , France, Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Drug safety, Pain, Risk Management & REMS | 2017 | English | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Public Health, Survey research | |
| GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries. | ||||
| Divino V., DeKoven M., Khan FA., Boye KS., Sapin H., Norrbacka K. | ||||
| Lilly. IMS authors: Divino V, DeKoven M | ||||
| Diabetes Ther. |
||||
| , Article | ||||
| , Belgium, France, Germany, Netherlands, Sweden | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28070733 | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2017 | English | , Retrospective database analysis | |
| SCHÉMAS THÉRAPEUTIQUES ET POSOLOGIQUES CHEZ DES PATIENTS AVEC UN DIABÈTE DE TYPE 2 (DT2) INITIANT UN TRAITEMENT PAR AGONISTE DU RÉCEPTEUR DU GLUCAGON-LIKE PEPTIDE 1 (AR GLP-1) EN EUROPE | ||||
| Norrbacka K, Divino V, Dekoven M, Boye KS | ||||
| Eli Lilly, IQVIA | ||||
| Societé Francophone du Diabete 2017 |
||||
| , Poster | ||||
| , Belgium, Canada, France, Germany, Italy, Netherlands | ||||
| Abstract: https://www.sfdiabete.org/sites/www.sfdiabete.org/files/files/evenements/17sfd_final_v12.pdf | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2017 | English | , Retrospective database analysis | |
| Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study | ||||
| Strongman H, Korhonen P, Williams R, Bahmanyar S, Hoti F, Christopher S, Majak M, Kool-Houweling L, Linder M, Dolin P, Heintjes EM | ||||
| EPID Research, Espoo, Finland | ||||
| BMJ Open Diab Res Care (2017);5: p. e000364-e000364 |
||||
| , Article | ||||
| , Finland, Netherlands, Sweden, UK | ||||
| Abstract: https://drc.bmj.com/content/5/1/e000364 | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2017 | English | , Epidemiological study, Retrospective database analysis | |
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. | ||||
| Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. | ||||
| 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden. | ||||
| Clinical Epidemiology |
||||
| , Article | ||||
| , Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK | ||||
| Abstract: http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pmc/articles/PMC4887072/ | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2016 | English | , Literature Review | |
| An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy. | ||||
| Richardson JL1, Stephens S1, Thomas SH1, Jamry-Dziurla A2, de Jong-van den Berg L3, Zetstra-van der Woude P3, Laursen M4, Hliva V5, Mt-Isa S6, Bourke A7, Dreyer NA8, Blackburn SC9. | ||||
| 1The UK Teratology Information ServiceNewcastle upon Tyne Hospitals NHS Foundation TrustNewcastle upon TyneUnited Kingdom; Institute of Cellular MedicineNewcastle UniversityNewcastle upon TyneUnited Kingdom. 2Department of Medical Genetics Poznan University of Medical Sciences Poznan Poland. 3Unit of PharmacoEpidemiology and PharmacoEconomics Department of Pharmacy University of Groningen Groningen Netherlands. 4Department of Data Delivery and Medicinal Product Statistics The Danish Health Data Authority Copenhagen Denmark. 5Quintiles Real-World and Late Phase Research St. Prex Switzerland. 6Imperial Clinical Trials Unit School of Public Health Imperial College London London United Kingdom. 7Real World Evidence Solutions IMS Health London United Kingdom. 8Quintiles Real-World & Late Phase Research Cambridge, MA United States. 9Quintiles Real-World and Late Phase Research Reading United Kingdom. | ||||
| , Article | ||||
| , Denmark, Netherlands, Poland, UK | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869218/pdf/publichealth_v2i1e13.pdf | ||||
| Condition | Year | Language | Analysis type | |
| , Drug safety, Womens Health | 2016 | English | , direct-to-patient research | |
| Costs of HPV-related cancers in The Netherlands. | ||||
| Ahmed Salem1, Shahbaz Pervaiz1, Vidya Breeveld-dwarkasing2, Dhont Patrick3, Slierendregt Bas2, Chantal van Gils1 | ||||
| 1 QuintilesIMS, Zaventem, Belgium 2 Sanofi-Pasteur MSD, Hoofddorp, The Netherlands 3 Sanofi-Pasteur MSD, Diegem, Belgium | ||||
| 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
||||
| , Abstract | ||||
| , Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2016 | English | , Real World Data | |
| Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study. | ||||
| Peyrin-Biroulet L1, Van Assche G2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11. | ||||
| 1Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. Electronic address: peyrinbiroulet@gmail.com. 2Division of Gastroenterology, University Hospitals Leuven, Leuven Belgium. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom. 10IMS Health, Real World Evidence Solutions, Spain. 11Merck & Co., Inc., Kenilworth, NJ, United States | ||||
| Dig Liver Dis. 2016 Jun;48(6):601-7. |
||||
| , Article | ||||
| , Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Gastrointestinal disorders | 2016 | English | , Burden of illness, Patient questionnaire, Survey research | |
| Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study | ||||
| Van Assche G1, Peyrin-Biroulet L2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11. | ||||
| 1Division of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gert.vanassche@uzleuven.be. 2Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica and Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK. 10IMS Health, Real World Evidence Solutions, Barcelona, Spain. 11Merck & Co., Inc., Rahway, NJ, United States. | ||||
| Dig Liver Dis. 2016 Jun;48(6):592-600 |
||||
| , Article | ||||
| , Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Gastrointestinal disorders | 2016 | English | , Burden of illness, Patient questionnaire | |
| THREE-MONTHLY LONG-ACTING ANTIPSYCHOTIC THERAPY RESULTS IN A BETTER TREATMENT CONTINUITY COMPARED TO A ONE-MONTHLY OR BI-WEEKLY TREATMENT IN SCHIZOPHRENIA | ||||
| Tedouri F1, Denee TR2, Malfait B3, Van Impe K2 | ||||
| 1Janssen Pharmaceutica NV, Beerse, Belgium, 2Janssen-Cilag BV, Tilburg, The Netherlands, 3Janssen-Cilag NV, Beerse, Belgium | ||||
| ISPOR 19th Annual European Congress Vienna, Austria October, 2016 |
||||
| , Poster | ||||
| , Belgium, Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Mental health | 2016 | English | , Retrospective database analysis | |
| The cost of HPV related cancers in the Netherlands. | ||||
| Salem S1, Pervaiz S1, Breeveld-dwarkasing V2, Dhont P3, Slierendregt B2, van Gils CW1 | ||||
| 1 IMS Health Belgium, Zaventem, Belgium 2 Sanofi Pasteur MSD, Hoofddorp, Netherlands 3 Sanofi Pasteur MSD, Diegem, Belgium | ||||
| 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
||||
| , Abstract | ||||
| , Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| 2016 | English | |||
| Treatment and dosing patterns among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Europe. | ||||
| Kirsi Norrbacka; Victoria Divino; Mitch DeKoven; Kristina Secnik Boye | ||||
| Lilly. IMS authors: Divino V, DeKoven M | ||||
| European Association for the Study of Diabetes 52nd annual meeting |
||||
| , Poster | ||||
| , Belgium, France, Germany, Netherlands, Sweden | ||||
| Abstract: https://www.easd.org/virtualmeeting/home.html#!resources/treatment-and-dosing-patterns-among-patients-with-type-2-diabetes-initiating-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-in-europe-5ef3fe71-7e5d-4bdd-8b32-b4187d2a9aac | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2016 | English | , Retrospective database analysis | |
| Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries | ||||
| Korhonen P, Heintjes E M, Williams R, Hoti F, Christopher S, Majak M, Kool-Houweling L, Strongman H, Linder M, Dolin P, Bahmanyar S | ||||
| EPID Research Ltd, Espoo, Finland | ||||
| BMJ (2016);354:i3903 |
||||
| , Article | ||||
| , Finland, Netherlands, Sweden, UK | ||||
| Abstract: https://researchonline.lshtm.ac.uk/4646203/1/Pioglitazone%20use%20and%20risk_GOLD%20VoR.pdf | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2016 | English | , Population Based Study, Retrospective cohort analysis | |
| Liver transplant associated with paracetamol overdose: results from the seven-country SALT study | ||||
| Sinem Ezgi Gulmez,1 Dominique Larrey,2 Georges- Philippe Pageaux,2 Jacques Bernuau,3 Franco Bissoli,4 Yves Horsmans,5 Douglas Thorburn,6 P. Aiden McCormick,7 Bruno Stricker,8 Massoud Toussi,9 Séverine Lignot-Maleyran,1 Sophie Micon,1 Fatima Hamoud,1 Régis Lassalle,1 Jérémy Jové,1 Patrick Blin1 & Nicholas Moore1 | ||||
| 1CIC Bordeaux CIC1401 Pharmaco-épidémiologie, Université de Bordeaux, F-33076 Bordeaux, France, 2CHU St Eloi Hospital, Liver Unit, Montpellier, France, 3Beaujon Hospital, Liver Unit, Clichy, France, 4Department of Internal Medicine, Clinica San Gaudenzio, Novara, Italy, 5Department of Gastroenterology, Louvain Catholic University, Louvain, Belgium, 6Liver Unit, Royal Free NHS Trust, London, UK, 7Liver Unit, St Vincent’s University Hospital and University College Dublin, Dublin, Ireland, 8Department of Epidemiology, Erasmus University, Rotterdam, Netherlands and 9IMSHealth, Real World Evidence Solutions, France | ||||
| British Journal of Clinical Pharmacology 2015 |
||||
| , Article | ||||
| , France, Greece, Ireland, Italy, Netherlands, Portugal, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Drug safety, Public Health | 2015 | English | , Epidemiological study | |
| TREATMENT CONTINUATION AND TREATMENT CHARACTERISTICS OF FOUR LONG ACTING ANTIPSYCHOTIC MEDICATIONS (PALIPERIDONE PALMITATE, RISPERIDONE MICROSPHERES, OLANZAPINE PAMOATE AND HALOPERIDOL DECANOATE) IN THE NETHERLANDS | ||||
| Denee TR1, Geerts P2, Sermon J2, Decuypere F3, Widrich C4, Rijntjes R1, Mulder CL5 | ||||
| 1Janssen-Cilag BV, Tilburg, The Netherlands, 2Janssen-Cilag NV, Beerse, Belgium, 3IMS Health, Vilvoorde, Belgium, 4IMS Health, The Netherlands, Capelle aan den IJssel, The Netherlands, 5Erasmus MC, Rotterdam, The Netherlands | ||||
| ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
| , Poster | ||||
| , Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Mental health | 2015 | English | , Retrospective database analysis | |
| Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies. | ||||
| McDonell AL1, Kiiskinen U2, Zammit DC3, Kotchie RW1, Thuresson PO3, Nicolay C4, Haslam T1, Bruinsma M5, Janszen-Van Oosterhout AJ6, Otto T4 | ||||
| 1IMS Health, London, UK; 2Eli Lilly and Company, Helsinki, Finland; 3IMS Health, Basel, Switzerland; 4Eli Lilly and Company, Bad Homburg, Germany; 5IMS Health, Rotterdam, the Netherlands; 6Eli Lilly Nederland, Houten, the Netherlands | ||||
| ClinicoEconomics and Outcomes Research, 2015; 7:95-103 |
||||
| , Article | ||||
| , Germany, Netherlands, UK | ||||
| Abstract: http://www.dovepress.com/estimating-the-real-world-daily-usage-and-cost-for-exenatide-twice-dai-peer-reviewed-article-CEOR | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2015 | English | , Retrospective database analysis | |
| NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett’s oesophagus: a populationbased case–control study | ||||
| Masclee GM1, Coloma PM2, Spaander MC3, Kuipers EJ3, Sturkenboom MC4. | ||||
| 1Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands. 2Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands. 3Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands. 4Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands | ||||
| BMJ Open. 2015 Jan 29;5(1):e006640. |
||||
| , Article | ||||
| , Netherlands, UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316430/pdf/bmjopen-2014-006640.pdf | ||||
| Condition | Year | Language | Analysis type | |
| , Gastrointestinal disorders, Oncology | 2015 | English | , Epidemiological study, Retrospective database analysis | |
| A DESCRIPTION OF REAL-WORLD TREATMENT WITH ABIRATERONE ACETATE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS IN THE POST-CHEMOTHERAPY SETTING IN FRANCE AND THE NETHERLANDS | ||||
| Dearden L1, Musingarimi P2, Shalet N3, Demuth D4, Garcia Alvarez L4, Muthutantri A4, Venerus A4, Lasry R4, Hankins M4, Maher T3 | ||||
| 1Janssen EMEA HEMAR, High Wycombe, UK, 2Janssen-Cilag Ltd., High Wycombe, UK, 3Janssen, High Wycombe, UK, 4IMS Health, London, UK | ||||
| ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
| , Poster | ||||
| , France, Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2015 | English | ||
| Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy | ||||
| Nancy A Dreyer1, MPH, PhD ;Stella CF Blackburn2, MBBS, MA, MSc ; Shahrul Mt-Isa3, BSc, PhD ; Jonathan L Richardson4,5, BBSc (Hons) ; Simon Thomas4,5, BSc, MD, FRCP ; Maja Laursen6, MSc, PhD ; • Priscilla Zetstra-van der Woude7, MSc ; Anna Jamry-Dziurla8, MSc ; Valerie Hliva9, PhD ; Alison Bourke10, BSc, MSc ; Lolkje de Jong-van den Berg7, PharmD, PhD | ||||
| 1Quintiles Real-World & Late Phase Research, Cambridge, MA, United States | ||||
| , Article | ||||
| , Denmark, Netherlands, Poland, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Drug safety, Pregnancy | 2015 | English | , direct-to-patient research, Internet or Interactive voice response system, Prospective study | |
| Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy. | ||||
| Dreyer NA1, Blackburn SC2, Mt-Isa S3, Richardson JL4, Thomas S4, Laursen M5, Zetstra-van der Woude P6, Jamry-Dziurla A7, Hliva V8, Bourke A9, de Jong-van den Berg L6. | ||||
| 1Quintiles Real-World & Late Phase Research Cambridge, MA United States. 2Quintiles Real-World & Late Phase Research Reading United Kingdom. 3Imperial College London United Kingdom. 4Institute of Cellular MedicineNewcastle UniversityNewcastle upon TyneUnited Kingdom; UK Teratology Information ServiceNewcastle HospitalsNHS Foundation TrustNewcastle upon TyneUnited Kingdom. 5Statens Serum Institut Copenhagen Denmark. 6University of Groningen Groningen Netherlands. 7Poznan University of Medical Sciences Poznan Poland. 8Quintiles Real-World & Late-Phase Research St. Prex Switzerland. 9IMS London United Kingdom. | ||||
| JMIR Public Health Surveill. 2015 Dec 22;1(2):e22. |
||||
| , Article | ||||
| , Denmark, Netherlands, Poland, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Drug safety, Womens Health | 2015 | English | , direct-to-patient research | |
| Bladder Cancer Risk in Relation to Exposure to Pioglitazone among Patients with T2DM in the Pan European Multi-Database Bladder Cancer Risk Characterisation Study | ||||
| Korhonen P, Haukka J, Tayler M, Haddad PM, Patel MX, Tiihonen J | ||||
| EPID Research Ltd, Espoo, Finland | ||||
| American Diabetes Association's 75th Scientific Session, Boston, USA, 5-9 June, 2015 |
||||
| , Finland, Netherlands, Sweden, UK | ||||
| Abstract: https://ada.scientificposters.com/epsAbstractADA.cfm?id=1 | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2015 | English | , Population Based Study, Retrospective database analysis | |
| Cost Utility of Telaprevir-PR (Peginterferon-Ribavirin) Versus Boceprevir-PR and Versus PR Alone in Chronic Hepatitis C in The Netherlands. | ||||
| Vellopoulou A, van Agthoven M, van der Kolk A, de Knegt RJ, Berdeaux G, et al. | ||||
| Appl Health Econ Health Policy, 2014, 12: 647–659 |
||||
| , Article | ||||
| , Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| 2014 | English | |||
| Selecting ovarian cancer patients for BRCA mutation testing - Findings from guidelines and literature review | ||||
| Eccles D1, Garcia E2, Balmana J3, Ehlken B4, Schroeder C4, Clune J5, Hirst C6, Potter D6, Tyczynski J6 | ||||
| 1 University of Southampton, Southampton, UK 2 Maastricht UMC, Maastricht, Netherlands 3 Familial Cancer Program, Barcelona, Spain 4 IMS Health, München, Germany 5 AstraZeneca, Melbourne, UK 6 AstraZeneca, Gaithersburg, USA | ||||
| Conference of The British Society of Genetic Medicine (BSGM), Liverpool, UK, 22–24 September, 2014 (Poster) |
||||
| , Abstract | ||||
| , Germany, Netherlands, Spain, UK, USA | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2014 | English | , Literature Review | |
| The incidence of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and The Netherlands is levelling off. | ||||
| Masclee GMC, Coloma PM, de Wilde M, Kuipers EJ & Sturkenboom M | ||||
| Erasmus University Medical Center Department of Medical Informatics | ||||
| Aliment Pharmacol Ther. 2014 Jun;39(11):1321-30. doi: 10.1111/apt.12759. Epub 2014 Apr 16 |
||||
| , Article | ||||
| , Netherlands, UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24738722 | ||||
| Condition | Year | Language | Analysis type | |
| , Gastrointestinal disorders, Oncology | 2014 | English | , Retrospective database analysis | |
| Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios. | ||||
| Hoogendoorn M1, Feenstra TL2, Asukai Y3, Borg S4, Hansen RN5, Jansson SA6, Samyshkin Y3, Wacker M7, Briggs AH8, Lloyd A3, Sullivan SD5, Rutten-van Mölken1 MP. | ||||
| 1Institute for Medical Technology Assessment, Erasmus University, Rotterdam, The Netherlands. 2Department for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Epidemiology, University Medical Centre Groningen, The Netherlands.3IMS Health, Health Economics and Outcomes Research, Real-World Evidence Solutions, London, UK 4The Swedish Institute for Health Economics, Lund, Sweden 5Pharmaceutical Outcomes Research and Policy Program, School of Pharmacy, University of Washington, Seattle, WA, USA 6The OLIN Studies, Luleå, Sweden 7Helmholtz Zentrum München, Institute of Health Economics and Health Care Management, Comprehensive Pneumology Center Munich, Neuherberg, Germany. 8Institute of Health & Wellbeing, University of Glasgow, UK. | ||||
| Value Health. 2014 Jul;17(5):525-36. |
||||
| , Article | ||||
| , Germany, Netherlands, Sweden, UK, USA | ||||
| Condition | Year | Language | Analysis type | |
| , Respiratory disease | 2014 | English | , Cost effectiveness | |
| Glucagon-like Peptide-1 receptor agonist treatment patterns among type 2 diabetes patients in six European countries. | ||||
| Divino V., DeKoven M., Hallinan S., Varol N., Wirta SB., Lee WC., Reaney M. | ||||
| Lilly. IMS authors: Divino V, DeKoven M | ||||
| Diabetes Ther. |
||||
| , Article | ||||
| , Belgium, France, Germany, Netherlands, Sweden, UK | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pubmed/25366334 | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2014 | English | , Retrospective database analysis | |
| Idiopathic acute liver injury in paediatric outpatients: incidence and signal detection in two European countries. | ||||
| Ferrajolo C1, Verhamme KM, Trifirò G, 't Jong GW, Giaquinto C, Picelli G, Oteri A, de Bie S, Valkhoff VE, Schuemie MJ, Mazzaglia G, Cricelli C, Rossi F, Capuano A, Sturkenboom MC.Capuano A, Sturkenboom MC. | ||||
| 1Campania Regional Center of Pharmacovigilance and Pharmacoepidemiology, Department of Experimental Medicine, Pharmacology Section, Second University of Naples, Via L. De Crecchio, 7, 80138, Naples, Italy | ||||
| Drug Saf. 2013 Oct;36(10):1007-16. doi: 10.1007/s40264-013-0045-7. |
||||
| , Article | ||||
| , Italy, Netherlands | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23591830 | ||||
| Condition | Year | Language | Analysis type | |
| , Drug safety, Pediatrics | 2013 | English | , Retrospective database analysis | |
| Cost effectiveness analysis of bendamustine as first line treatment for chronic lymphocytic leukaemia in the Netherlands. | ||||
| Vandekerckhove S1, Holtzer-Goor K2, Van Den Steen D1, van Megen Y3, Huijgens P4, Lamotte M1, Uyl- de Groot C5 | ||||
| 1 IMS Health, Vilvoorde, Belgium 2 iMTA, Rotterdam, Zuid Holland, Netherlands 3 Mundipharma Pharmaceuticals, Hoevelaken, Netherlands 4 VU University Medical Center, Amsterdam, Netherlands 5 Erasmus University, Rotterdam, Netherlands | ||||
| 15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany |
||||
| , Abstract, Poster | ||||
| , Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2012 | English | , Cost effectiveness, Cost utility | |
| Frequency of administration of biologics has an impact on treatment decision making. | ||||
| Chevalier P1, Black C2,3, Lamotte M1, Crombach J4, Huismans J4, Rosiek R5, Fan T3 | ||||
| 1 IMS HEOR, Vilvoorde, Belgium 2 St. John’s University 3 Merck & Co. 4 MSD, Netherlands 5 Medithuis B.V. | ||||
| 15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany |
||||
| , Abstract, Poster | ||||
| , Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Rheumatology | 2012 | English | , Retrospective database analysis | |
| The cost-utility of teleprevir in combination with peginterfeon alpha and ribavirin (PR) as compared to the combination boceprevir with PR and to PR alone in the management of chronic hepatitis C in the Netherlands. | ||||
| Vellopoulou K1, Van Agthoven M2, Van Der Kolk A2, Lamotte M1, Cure S3, Bianic F4 | ||||
| 1 IMS Health, Vilvoorde, Belgium 2 Janssen-Cilag BV, Tilburg, Netherlands 3 OptumInsight, Uxbridge, Middlesex, United Kingdom 4 OptumInsight, Nanterre, France | ||||
| 15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany |
||||
| , Abstract, Poster | ||||
| , Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Infectious disease | 2012 | English | , Cost effectiveness, Cost utility | |
| Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based study. | ||||
| Valkhoff VE1, van Soest EM, Mazzaglia G, Molokhia M, Schade R, Trifiro G, Goldstein JL, Hernandez-Diaz S, Kuipers EJ, Sturkenboom MC | ||||
| 1Erasmus University Medical Centre, Rotterdam, The Netherlands | ||||
| Arthritis Rheum. 2012 Aug;64(8):2792-802. doi: 10.1002/art.34433. |
||||
| , Article | ||||
| , Italy, Netherlands, UK | ||||
| Abstract: http://onlinelibrary.wiley.com/doi/10.1002/art.34433/full | ||||
| Condition | Year | Language | Analysis type | |
| , Gastrointestinal disorders | 2012 | English | , Retrospective database analysis | |
| The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease. | ||||
| Mokhles MM1, Trifirò G, Dieleman JP, Haag MD, van Soest EM, Verhamme KM, Mazzaglia G, Herings R, Luise Cd, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, Camp Gv, Zanettini R, Sturkenboom MC | ||||
| 1Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands. | ||||
| Pharmacol Res. 2012 Mar;65(3):358-64. doi: 10.1016/j.phrs.2011.11.009. Epub 2011 Nov 23. |
||||
| , Article | ||||
| , Italy, Netherlands, UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22123498 | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Drug safety, Neurological disorders | 2012 | English | , Retrospective database analysis | |
| Observational evidence that urbanisation and neighbourhood deprivation are associated with escalation in chronic pharmacological pain treatment: a longitudinal population-based study in the Netherlands. | ||||
| Leue C1, Buijs S2, Strik J, Lousberg R, Smit J2, van Kleef M, van Os J. | ||||
| Department of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University Medical Centre, Maastricht, The Netherlands; 2IMS Health BV, Capelle aan den IJssel, The Netherlands | ||||
| , Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Pain | 2012 | English | , Retrospective database analysis | |
| Combining electronic healtcare databases in Europe to allow for large-scale drug safety monitoring : the EU-ADR Project. | ||||
| Coloma PM, Schuemie MJ, trifiro G, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Giaquinto C, Corrao G, Pedersen L, Van Der Lei J, Sturkenboom M, EU-ADR Consortium. | ||||
| Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):1-11. doi: 10.1002/pds.2053. Epub 2010 Nov 8. |
||||
| , Article | ||||
| , Denmark, Italy, Netherlands, UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21182150 | ||||
| Condition | Year | Language | Analysis type | |
| , Methodology | 2011 | English | ||
| EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection. | ||||
| Trifiro G, Patadia V, Schuemie MJ, Coloma PM, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, giaquinto C, Scotti L, Avillach P, Sturkenboom MC, van der Lei J, Eu-Adr group. | ||||
| Stud Health Technol Inform. 2011;166:25-30. |
||||
| , Article | ||||
| , Denmark, Italy, Netherlands, UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21685607 | ||||
| Condition | Year | Language | Analysis type | |
| , Methodology | 2011 | English | ||
| Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases”. | ||||
| van Soest EM, Valkhoff VE, Mazzaglia G, Schade R, Molokhia M, Goldstein JL, Hernández-Díaz S, Trifirò G, Dieleman JP, Kuipers EJ, Sturkenboom MC. | ||||
| Gut. 2011 Dec;60(12):1650-9. doi: 10.1136/gut.2011.239848. Epub 2011 Jun 2. |
||||
| , Article | ||||
| , Italy, Netherlands, UK | ||||
| Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21636644 | ||||
| Condition | Year | Language | Analysis type | |
| , Gastrointestinal disorders, Pain | 2011 | English | ||
| Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands | ||||
| Netelenbos JC1, Geusens PP, Ypma G, Buijs SJ. | ||||
| 1Department of Internal Medicine, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands | ||||
| Osteoporos Int. 2011 May;22(5):1537-46. |
||||
| , Article | ||||
| , Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Medication compliance, Musculoskeletal disease | 2011 | English | , Retrospective database analysis | |
| Treatment of moderate to severe pain with oxycodone/naloxone to reduce opioid-induced constipation: a cost-utility analysis in Belgium and The Netherlands. | ||||
| Gerlier L1, Lamotte M1, Van Megen Y2 | ||||
| 1 IMS Health, Brussels, Belgium 2 Mundipharma Pharmaceuticals, Hoevelaken, The Netherlands | ||||
| ISPOR 12th Annual European Congress, 2009, October 24-27, Paris, France |
||||
| , Poster | ||||
| , Belgium, Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Gastrointestinal disorders | 2009 | English | , Cost utility | |
| Management of opioid induced constipation (OIC) in pain patients: a cost of illness study in Belgium and the Netherlands. | ||||
| Caekelbergh K1, Lamotte M1, Van Megen Y2 | ||||
| 1 IMS Health, Brussels, Belgium 2 Mundipharma Pharmaceuticals BV, Hoevelaken, The Netherlands | ||||
| ISPOR 12th Annual European Congress, 2009, October 24-27, Paris, France |
||||
| , Poster | ||||
| , Belgium, Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| 2009 | English | , Cost of illness | ||
| Discovery Benelux: comparison of rosuvastatin with atorvastatin in hypercholesterolaemia. | ||||
| Herregods MC, Daubresse JC, Michel G, Lamotte M, Vissers E, Vandenhoven G | ||||
| Acta Cardiologica, 2008, 63(4): 493-499 |
||||
| , Article | ||||
| , Belgium, Luxembourg, Luxemburg, Netherlands | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease | 2008 | English | , Economic evaluation | |
| Cost of scheduled and unscheduled asthma management in seven EU countries. | ||||
| Williams AE1, Lloyd AC2, Watson L1, Rabe KF3. | ||||
| 1 GlaxoSmithKline R&D, Greenford, 2 Fourth Hurdle Consulting Ltd, London, UK. 3 Leiden University Medical Centre, Leiden, The Netherlands | ||||
| European Respiratory Review 2006; 15:(98): 4–9 |
||||
| , Manuscript in preparation | ||||
| , France, Germany, Italy, Netherlands, Spain, Sweden, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Respiratory disease | 2006 | English | , Burden of illness | |